{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:10:57Z","timestamp":1771539057287,"version":"3.50.1"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002016","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T20:14:57Z","timestamp":1301602497000},"page":"e1002016","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":89,"title":["Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome \u2014 Clozapine-Induced Agranulocytosis as a Case Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Lun","family":"Yang","sequence":"first","affiliation":[]},{"given":"Kejian","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Anil G.","family":"Jegga","sequence":"additional","affiliation":[]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Leming","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Chunling","family":"Wan","sequence":"additional","affiliation":[]},{"given":"Xizhi","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Shengying","family":"Qin","sequence":"additional","affiliation":[]},{"given":"Guang","family":"He","sequence":"additional","affiliation":[]},{"given":"Guoyin","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).","volume":"374","author":"J Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/14622416.9.8.1101","article-title":"Clozapine-induced agranulocytosis and its genetic determinants.","volume":"9","author":"C Opgen-Rhein","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.","volume":"329","author":"JM Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(77)91410-6","article-title":"Clozapine and agranulocytosis.","volume":"1","author":"HJ Senn","year":"1977","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.","volume":"42","author":"JB Singer","year":"2010","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.","volume":"41","author":"AK Daly","year":"2009","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/clpt.2009.42","article-title":"Generating genome-scale candidate gene lists for pharmacogenomics.","volume":"86","author":"NT Hansen","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng0407-426","article-title":"PharmGKB: a logical home for knowledge relating genotype to drug response phenotype.","volume":"39","author":"RB Altman","year":"2007","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd2423","article-title":"Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.","volume":"6","author":"RA Wilke","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/bioinformatics\/btp369","article-title":"A CitationRank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction.","volume":"25","author":"L Yang","year":"2009","journal-title":"Bioinformatics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/clpt.2008.274","article-title":"Data-driven methods to discover molecular determinants of serious adverse drug events.","volume":"85","author":"AP Chiang","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrd1720","article-title":"Elucidating mechanisms of drug-induced toxicity.","volume":"4","author":"DC Liebler","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e1000441","DOI":"10.1371\/journal.pcbi.1000441","article-title":"Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.","volume":"5","author":"L Yang","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/minf.200900081","article-title":"Structure-based approaches to target fishing and ligand profiling.","volume":"29","author":"D Rognan","year":"2010","journal-title":"Molecular Informatics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e12214","DOI":"10.1371\/journal.pone.0012214","article-title":"Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements.","volume":"5","author":"E De Franchi","year":"2010","journal-title":"PLoS ONE"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/wsbm.114","article-title":"Role of systems pharmacology in understanding drug adverse events.","volume":"3","author":"SI Berger","year":"2010","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.","volume":"3","author":"L Xie","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1142\/S0192415X02000156","article-title":"Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants.","volume":"30","author":"YZ Chen","year":"2002","journal-title":"Am J Chin Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/00002512-200623120-00002","article-title":"Adverse effects of atypical antipsychotics in the elderly: a review.","volume":"23","author":"P Gareri","year":"2006","journal-title":"Drugs Aging"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004714-200004000-00032","article-title":"Olanzapine: safe during clozapine-induced agranulocytosis.","volume":"20","author":"LK Oyewumi","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-199805000-00007","article-title":"Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.","volume":"13","author":"B Finkel","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e9568","DOI":"10.1371\/journal.pone.0009568","article-title":"Identifying unexpected therapeutic targets via chemical-protein interactome.","volume":"5","author":"L Yang","year":"2010","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"W406","DOI":"10.1093\/nar\/gkp312","article-title":"SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome.","volume":"37","author":"L Yang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS).","volume":"106","author":"B Lomenick","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt1519","article-title":"Protein promiscuity and its implications for biotechnology.","volume":"27","author":"I Nobeli","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1073\/pnas.0900191106","article-title":"Identifying the proteins to which small-molecule probes and drugs bind in cells.","volume":"106","author":"SE Ong","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS).","volume":"106","author":"B Lomenick","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1011115820450","article-title":"DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases.","volume":"15","author":"TJ Ewing","year":"2001","journal-title":"J Comput Aided Mol Des"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/jm030161o","article-title":"Multiple active site corrections for docking and virtual screening.","volume":"47","author":"GP Vigers","year":"2004","journal-title":"J Med Chem"},{"key":"ref30","first-page":"295","article-title":"[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].","volume":"48","author":"Y Guzelcan","year":"2006","journal-title":"Tijdschr Psychiatr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V86.10.3835.bloodjournal86103835","article-title":"The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.","volume":"86","author":"D Corzo","year":"1995","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood.V89.11.4167","article-title":"Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups.","volume":"89","author":"D Turbay","year":"1997","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1399-0039.2003.00133.x","article-title":"NQO2 gene is associated with clozapine-induced agranulocytosis.","volume":"62","author":"O Ostrousky","year":"2003","journal-title":"Tissue Antigens"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1021\/jm100054f","article-title":"Heat shock protein 70 (hsp70) as an emerging drug target.","volume":"53","author":"CG Evans","year":"2010","journal-title":"J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"W424","DOI":"10.1093\/nar\/gkq480","article-title":"SiMMap: a web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties.","volume":"38","author":"YF Chen","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.jcp.0000144891.52858.a6","article-title":"Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.","volume":"24","author":"I Mosyagin","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.21433","article-title":"Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management.","volume":"84","author":"D Tesfa","year":"2009","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/bioinformatics\/btp465","article-title":"Network analyses in systems pharmacology.","volume":"25","author":"SI Berger","year":"2009","journal-title":"Bioinformatics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.","volume":"313","author":"J Lamb","year":"2006","journal-title":"Science"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.","volume":"25","author":"M Ashburner","year":"2000","journal-title":"Nature Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.58.1.207","article-title":"Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.","volume":"58","author":"DP Williams","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"D411","DOI":"10.1093\/nar\/gkj141","article-title":"Human protein reference database\u20132006 update.","volume":"34","author":"GR Mishra","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e1000662","DOI":"10.1371\/journal.pcbi.1000662","article-title":"Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets.","volume":"6","author":"S Suthram","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1158140","article-title":"Drug target identification using side-effect similarity.","volume":"321","author":"M Campillos","year":"2008","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs.","volume":"462","author":"MJ Keiser","year":"2009","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4155\/tde.10.64","article-title":"Personalized medicine: the impact on chemistry.","volume":"1","author":"J Watkins","year":"2010","journal-title":"Ther Deliv"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry.","volume":"25","author":"MJ Keiser","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/ci800079x","article-title":"Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics.","volume":"48","author":"F Nigsch","year":"2008","journal-title":"J Chem Inf Model"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e12063","DOI":"10.1371\/journal.pone.0012063","article-title":"A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways.","volume":"5","author":"I Wallach","year":"2010","journal-title":"PLoS ONE"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","article-title":"Drug off-target effects predicted using structural analysis in the context of a metabolic network model.","volume":"6","author":"RL Chang","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.","volume":"28","author":"L Shi","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0891-5849(00)00306-3","article-title":"Regulation of genes encoding NAD(P)H:quinone oxidoreductases.","volume":"29","author":"AK Jaiswal","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ajcn\/74.6.714","article-title":"gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.","volume":"74","author":"Q Jiang","journal-title":"Am J Clin Nutr"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(24)37177-0","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.","volume":"283","author":"DP Williams","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0167-5699(94)90018-3","article-title":"Oxidative stress as a mediator of apoptosis.","volume":"15","author":"TM Buttke","year":"1994","journal-title":"Immunol Today"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.","volume":"8","author":"A Kindmark","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"ref57","article-title":"Delayed drug hypersensitivity: models of T-cell stimulation.","author":"J Adam","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mcna.2010.04.003","article-title":"Drug hypersensitivity reactions: pathomechanism and clinical symptoms.","volume":"94","author":"WJ Pichler","year":"2010","journal-title":"Med Clin North Am"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.","volume":"28","author":"D Chessman","year":"2008","journal-title":"Immunity"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.","volume":"102","author":"SI Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: current understanding.","volume":"47","author":"J Uetrecht","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"12323","DOI":"10.1021\/bi970962r","article-title":"Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.","volume":"36","author":"K Hamasaki","year":"1997","journal-title":"Biochemistry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/cr.2007.27","article-title":"A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir.","volume":"17","author":"CY Li","year":"2007","journal-title":"Cell Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.","volume":"352","author":"S Kobayashi","year":"2005","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.","volume":"293","author":"ME Gorre","year":"2001","journal-title":"Science"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs.","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1073\/pnas.1000138107","article-title":"Discovery of drug mode of action and drug repositioning from transcriptional responses.","volume":"107","author":"F Iorio","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/clpt.2009.103","article-title":"Systematic evaluation of drug-disease relationships to identify leads for novel drug uses.","volume":"86","author":"AP Chiang","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002018-200326100-00002","article-title":"Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions.","volume":"26","author":"ZL Ji","year":"2003","journal-title":"Drug Saf"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/bioinformatics\/btm139","article-title":"DITOP: drug-induced toxicity related protein database.","volume":"23","author":"JX Zhang","year":"2007","journal-title":"Bioinformatics"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: Therapeutic Target Database.","volume":"30","author":"X Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2105-9-104","article-title":"PDTD: a web-accessible protein database for drug target identification.","volume":"9","author":"Z Gao","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"D142","DOI":"10.1093\/nar\/gkp846","article-title":"The Universal Protein Resource (UniProt) in 2010.","volume":"38","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis.","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation.","volume":"29","author":"ST Sherry","year":"2001","journal-title":"Nucleic Acids Res"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:36:35Z","timestamp":1741116995000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002016"}},"subtitle":[],"editor":[{"given":"Russ B.","family":"Altman","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":75,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002016","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]}}}